EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 397 filers reported holding EXELIXIS INC in Q3 2022. The put-call ratio across all filers is 0.65 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $215,834 | +4.8% | 9,878 | 0.0% | 0.02% | -11.5% |
| Q2 2022 | $206,000 | -8.0% | 9,878 | 0.0% | 0.03% | 0.0% |
| Q1 2022 | $224,000 | +7.2% | 9,878 | 0.0% | 0.03% | +8.3% |
| Q3 2021 | $209,000 | -6.3% | 9,878 | 0.0% | 0.02% | -11.1% |
| Q1 2021 | $223,000 | -7.9% | 9,878 | 0.0% | 0.03% | -25.0% |
| Q3 2020 | $242,000 | +3.0% | 9,878 | 0.0% | 0.04% | -2.7% |
| Q2 2020 | $235,000 | +11.4% | 9,878 | 0.0% | 0.04% | +8.8% |
| Q2 2019 | $211,000 | -10.2% | 9,878 | 0.0% | 0.03% | -8.1% |
| Q1 2019 | $235,000 | +21.1% | 9,878 | 0.0% | 0.04% | +48.0% |
| Q4 2018 | $194,000 | +10.9% | 9,878 | 0.0% | 0.02% | -3.8% |
| Q3 2018 | $175,000 | -17.8% | 9,878 | 0.0% | 0.03% | -13.3% |
| Q2 2018 | $213,000 | – | 9,878 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 17,416,738 | $422,007,000 | 64.06% |
| Matrix Capital Management Company, LP | 15,117,460 | $366,296,000 | 11.71% |
| Rhenman & Partners Asset Management AB | 1,050,000 | $25,442,000 | 3.25% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 254,334 | $6,163,000 | 2.40% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 790,148 | $19,145,000 | 1.30% |
| Jupiter Investment Management Ltd | 4,182,760 | $101,348,000 | 1.06% |
| INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 50,818 | $1,231,000 | 0.70% |
| C M BIDWELL & ASSOCIATES LTD | 17,475 | $423,000 | 0.65% |
| QCM Cayman, Ltd. | 9,562 | $232,000 | 0.60% |
| Handelsinvest Investeringsforvaltning | 98,500 | $2,387,000 | 0.56% |